These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 18816641

  • 1. Health-care providers' compliance with childhood acute lymphoblastic leukemia protocol in Indonesia.
    Sitaresmi MN, Mostert S, Gundy CM, Sutaryo, Veerman AJ.
    Pediatr Blood Cancer; 2008 Dec; 51(6):732-6. PubMed ID: 18816641
    [Abstract] [Full Text] [Related]

  • 2. Attitude of health-care providers toward childhood leukemia patients with different socio-economic status.
    Mostert S, Sitaresmi MN, Gundy CM, Sutaryo, Veerman AJ.
    Pediatr Blood Cancer; 2008 May; 50(5):1001-5. PubMed ID: 17676594
    [Abstract] [Full Text] [Related]

  • 3. Influence of socioeconomic status on childhood acute lymphoblastic leukemia treatment in Indonesia.
    Mostert S, Sitaresmi MN, Gundy CM, Sutaryo, Veerman AJ.
    Pediatrics; 2006 Dec; 118(6):e1600-6. PubMed ID: 17074838
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic effectiveness of the ALL-XH-99 protocol for childhood acute lymphoblastic leukemia.
    Wang YR, Jin RM, Xu JW, Xiao Y, Zhou DF, Zhang ZQ.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):1-4. PubMed ID: 18289459
    [Abstract] [Full Text] [Related]

  • 5. Chemotherapy-related side effects in childhood acute lymphoblastic leukemia in Indonesia: parental perceptions.
    Sitaresmi MN, Mostert S, Purwanto I, Gundy CM, Sutaryo, Veerman AJ.
    J Pediatr Oncol Nurs; 2009 Feb; 26(4):198-207. PubMed ID: 19726791
    [Abstract] [Full Text] [Related]

  • 6. Compliance with American Academy of Pediatrics and American Public Health Association illness exclusion guidelines for child care centers in Maryland: who follows them and when?
    Copeland KA, Harris EN, Wang NY, Cheng TL.
    Pediatrics; 2006 Nov; 118(5):e1369-80. PubMed ID: 17079538
    [Abstract] [Full Text] [Related]

  • 7. Health-care providers' perspectives on childhood cancer treatment in Manado, Indonesia.
    Mostert S, Gunawan S, van Dongen JA, van de Ven PM, Sitaresmi MN, Wolters EE, Veerman AJ, Mantik M, Kaspers GJ.
    Psychooncology; 2013 Nov; 22(11):2522-8. PubMed ID: 23703746
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Does aid reach the poor? Experiences of a childhood leukaemia outreach-programme.
    Mostert S, Sitaresmi MN, Gundy CM, Sutaryo, Veerman AJ.
    Eur J Cancer; 2009 Feb; 45(3):414-9. PubMed ID: 18977652
    [Abstract] [Full Text] [Related]

  • 11. HealthCare Providers' and Parents' Perspectives on Complementary Alternative Medicine in Children with Cancer in Indonesia.
    Susilawati D, Sitaresmi M, Handayani K, Ven Pv, Sutaryo, Kaspers G, Mostert S.
    Asian Pac J Cancer Prev; 2016 Feb; 17(7):3235-42. PubMed ID: 27509956
    [Abstract] [Full Text] [Related]

  • 12. Outcome of childhood acute lymphoblastic leukemia with induction failure treated by the Japan Association of Childhood Leukemia study (JACLS) ALL F-protocol.
    Suzuki N, Yumura-Yagi K, Yoshida M, Hara J, Nishimura S, Kudoh T, Tawa A, Usami I, Tanizawa A, Hori H, Ito Y, Miyaji R, Oda M, Kato K, Hamamoto K, Osugi Y, Hashii Y, Nakahata T, Horibe K, Japan Association of Childhood Leukemia Study (JACLS).
    Pediatr Blood Cancer; 2010 Jan; 54(1):71-8. PubMed ID: 19813250
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. High-risk childhood acute lymphoblastic leukemia in China: factors influencing the treatment and outcome.
    Luo XQ, Ke ZY, Huang LB, Guan XQ, Zhang YC, Zhang XL.
    Pediatr Blood Cancer; 2009 Feb; 52(2):191-5. PubMed ID: 18989886
    [Abstract] [Full Text] [Related]

  • 15. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P, Landman-Parker J, Cayuela JM, Asnafi V, Labopin M, Gandemer V, Perel Y, Michel G, Leblanc T, Schmitt C, Fasola S, Hagemejier A, Sigaux F, Auclerc MF, Douay L, Leverger G, Baruchel A.
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Acute lymphoblastic leukemia in the Department of Child Health, School of Medicine, University of North Sumatera/Dr. Pirngadi Hospital Medan (1980-1988).
    Arifin Z, Nasution F, Sutjipto A.
    Paediatr Indones; 1991 Nov; 31(7-8):185-90. PubMed ID: 1792087
    [Abstract] [Full Text] [Related]

  • 18. [Recent advance in treatment of childhood acute lymphoblastic leukemia].
    Watanabe A.
    Gan To Kagaku Ryoho; 2007 Feb; 34(2):150-5. PubMed ID: 17301519
    [Abstract] [Full Text] [Related]

  • 19. New decision support tool for treatment intensity choice in childhood acute lymphoblastic leukemia.
    Pedreira CE, Macrini L, Land MG, Costa ES.
    IEEE Trans Inf Technol Biomed; 2009 May; 13(3):284-90. PubMed ID: 19423428
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.